MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo. - Saporito MS; Ochman AR; Lipinski CA; Handler JA; Reaume AG (The Journal of pharmacology and experimental therapeutics, 2012)